It is known that levels of TNF-α are augmented in IBD patients and that this cytokine is linked to the disease’s symptoms (Vassalli, 1992; Papadakis and Targan, 2000; Adegbola et al., 2018). Here, TNF is linked to irritable bowel syndrome.